GenomeWeb is hosting a virtual expert panel to discuss challenges, opportunities, and controversies related to informing clinicians, cancer patients, and their families of potential germline insights after receiving somatic testing.
This case-based discussion will provide an overview of best practices and lost opportunities, along with examples of the impact of current reporting practices on clinicians, patients, and their families.